CryoLife completed its acquisition of JOTEC, a developer of aortic surgical grafts. Deutsche Bank served as administrative agent and collateral agent for financing supporting the transaction.
CryoLife, a medical device and tissue processing company focused on cardiac and vascular surgery, entered into a definitive agreement to acquire JOTEC.
CryoLife has received a commitment from Capital One, Healthcare Financial, Fifth Third and Citizens Bank to provide a $95 million secured credit facility to support the acquisition of On-X Life Technologies.
Medical device maker CryoLife will acquire On-X Life Technologies Holdings in a $130 million deal. Capital One, Fifth Third and Citizens provided a $95 million facility to support the acquisition.